Zevra Therapeutics Inc (ZVRA)
9.03
+0.37
(+4.27%)
USD |
NASDAQ |
Nov 14, 16:00
9.02
-0.01
(-0.11%)
After-Hours: 07:45
Zevra Therapeutics Cash and Short Term Investments (Quarterly): 49.26M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 49.26M |
| March 31, 2024 | 52.72M |
| December 31, 2023 | 67.74M |
| September 30, 2023 | 83.43M |
| June 30, 2023 | 87.37M |
| March 31, 2023 | 95.28M |
| December 31, 2022 | 82.85M |
| September 30, 2022 | 75.89M |
| June 30, 2022 | 80.98M |
| March 31, 2022 | 101.58M |
| December 31, 2021 | 112.35M |
| September 30, 2021 | 131.50M |
| June 30, 2021 | 132.30M |
| March 31, 2021 | 75.92M |
| December 31, 2020 | 4.213M |
| September 30, 2020 | 5.267M |
| June 30, 2020 | 6.369M |
| March 31, 2020 | 2.356M |
| December 31, 2019 | 3.217M |
| September 30, 2019 | 6.518M |
| Date | Value |
|---|---|
| June 30, 2019 | 7.308M |
| March 31, 2019 | 13.44M |
| December 31, 2018 | 21.67M |
| September 30, 2018 | 13.03M |
| June 30, 2018 | 28.20M |
| March 31, 2018 | 34.62M |
| December 31, 2017 | 42.23M |
| September 30, 2017 | 45.24M |
| June 30, 2017 | 53.49M |
| March 31, 2017 | 61.12M |
| December 31, 2016 | 67.76M |
| September 30, 2016 | 63.52M |
| June 30, 2016 | 82.64M |
| March 31, 2016 | 111.00M |
| December 31, 2015 | 51.32M |
| September 30, 2015 | 59.01M |
| June 30, 2015 | 64.22M |
| March 31, 2015 | 10.27M |
| December 31, 2014 | 10.26M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.356M
Minimum
Mar 2020
132.30M
Maximum
Jun 2021
65.82M
Average
75.92M
Median
Mar 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 2.483B |
| Vanda Pharmaceuticals Inc | 376.26M |
| BioCardia Inc | 1.421M |
| Xeris Biopharma Holdings Inc | 69.40M |
| Instil Bio Inc | 148.61M |